PLoS ONE, 2023 · DOI: https://doi.org/10.1371/journal.pone.0280304 · Published: January 13, 2023
This research investigates the potential of hair-follicle-associated pluripotent (HAP) stem cells to repair intracerebral hemorrhage (ICH) and reduce neuroinflammation. The study found that HAP stem cells can differentiate into various brain cells and suppress inflammation in a mouse model of ICH. The authors suggest that HAP stem cells offer advantages over other stem cell types due to their non-tumorigenic nature and autologous potential.
HAP stem cells could be a novel therapeutic approach for treating ICH, a condition with limited effective treatments.
HAP stem cells offer benefits like non-tumorigenicity and autologous use, potentially overcoming limitations of iPSCs and ESCs.
This research supports the use of stem cell therapy for neural repair and functional recovery after brain injury.